Biotech Values

[ghmm]

Discussions are underway with the potential pharma partner and they expect to have a decision in 4Q this year of the analogs and/or RHI (BIOD-105 and BIOD-107) that will move forward (and presumably whether or not they will be doing that alone or in conjunction with the potential big pharma partner).

So they are in a race with HALO of who will partner first... Of course the likely outcome is rkrw is right and they (at least Halozyme) will just keep talking about partnering again all of next year too